2014
DOI: 10.1016/j.anpede.2013.11.008
|View full text |Cite
|
Sign up to set email alerts
|

Adverse reactions to human papillomavirus vaccine in the Valencian Community (2007–2011)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 13 publications
1
5
0
Order By: Relevance
“…Reporting rate of seizures accompanying syncope after vaccination with qHPV in Slovenia was similar to the rates reported from Spain and Australia (3.4 vs 3.2 and 2.6 per 100,000 qHPV doses distributed, respectively) [22,25]. However, monitoring of qHPV occurred between 2006 and 2009, during which a total of 600,558 doses were administered in the Vaccine Safety Database (VSD) population, and no association between qHPV and seizures, whether recurrent or new onset was observed [14].…”
Section: Discussionsupporting
confidence: 64%
See 2 more Smart Citations
“…Reporting rate of seizures accompanying syncope after vaccination with qHPV in Slovenia was similar to the rates reported from Spain and Australia (3.4 vs 3.2 and 2.6 per 100,000 qHPV doses distributed, respectively) [22,25]. However, monitoring of qHPV occurred between 2006 and 2009, during which a total of 600,558 doses were administered in the Vaccine Safety Database (VSD) population, and no association between qHPV and seizures, whether recurrent or new onset was observed [14].…”
Section: Discussionsupporting
confidence: 64%
“…However, monitoring of qHPV occurred between 2006 and 2009, during which a total of 600,558 doses were administered in the Vaccine Safety Database (VSD) population, and no association between qHPV and seizures, whether recurrent or new onset was observed [14]. A relatively higher reporting rate of headache was reported in Slovenia in comparison to the US and Spain (40.3 per 100,000 qHPV doses distributed vs 4.1 and 23.5, respectively), and relatively higher reporting rate of fever in comparison to the US (35.3 vs 0.4 per 100,000 qHPV doses distributed) [20,22,27]. In contrast, although local reactions are usually frequently reported AEFIs with qHPV that are generally of short duration and resolve spontaneously, in our analyses only one fifth of reports with AEFIs with qHPV involved local reactions, mainly pain and swelling [28].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Human papillomavirus (HPV) vaccination is reported with more adverse reactions than other vaccines (73). Common neurologic complications after HPV vaccination have been complex regional pain syndrome, postural orthostatic tachycardia syndrome (POTS), and FM, all reported with concurrent small fiber neuropathy.…”
Section: Vaccination and Sfnmentioning
confidence: 99%
“…Those cases were extensively covered by all media at the regional and national levels [22]. Subsequently, in 2013, a study described the suspected adverse reactions following the HPV vaccine during the first four years of HPV vaccination [23].…”
Section: Introductionmentioning
confidence: 99%